多巴胺转运体显像剂<sup>11</sup>C-CFT和<sup>18</sup>F-CFT及其临床应用进展

柴黎明; 杨小丰; 王爽; 吴君; 赵周社; 柴黎明; 杨小丰; 王爽; 吴君; 赵周社

doi:10.3760/cma.j.issn.1673-4114.2009.04.012

[1]

陈生第.帕金森病临床新技术.北京:人民军医出版社,2002:41-104.

[2]

Ishikawa A,Takahashi H.Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism.J Neurol,1998,245(11 suppl 3):P4-P9.

[3]

胡丹,曹卫,孙圣刚.帕金森病核医学诊断技术研究进展.国际神经病学神经外科学杂志,2007,34(1):83-86.

[4]

Cham R,Studenski SA,Perera S,et al.Striatal dopaminergic denervation and gait in healthy adults.Exp Brain Res,2008,185(3):391-398.

[5]

Rinne JO,Ruottinen H,Bergman J,et al.Usefulness of a dopamine transporter PET ligand[(18)F] beta-CFT in assessing disability in Parkinson's disease.J Neurol Neurosurg Psychiatry,1999,67(6):737-741.

[6]

张锦明,田嘉禾,郭喆,等.在线自动化制备多巴胺转运蛋白显像剂¹¹C-β-CFT,中华核医学杂志,2005,25(3):142-145.

[7]

Haaparanta M,Bergman J,Laakso A,et al.[¹⁸F] CFT ([^l8F] WIN 35,428),a radioligand to study the dopamine transporter with PET;biodistribution in rats.Synapse,1996,23(4):321-327,.

[8]

Chitneni SK,Garreau L,Cleynhens B,et al.Improved synthesis and metabolic stability analysis of the dopamine transporter ligand[¹⁸F] FECT.Nucl Med Biol,2008,35(1); 75-82.

[9]

Emond P,Guilloteau D,Chalon S.PE2I:a radiopharmaceutical for in vivo exploration of the dopamine transporter.CNS Neurosci Ther,2008,14(1):47-64.

[10]

Ouchi Y,Kanno T,Okada H,et al.Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease.Brain,2001,124(pt 4):784-792.

[11]

Rinne JO,Laine M,Kaasinen V,et al.Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia.Neurology,2002,58(10):1489-1493.

[12]

Weng YH,Yen TC,Chen MC,et al.Sensitivity and specificity of ^99mTc-TRODAT-l SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects.J Nucl Med,2004,45(3):393-401.

[13]

何婷婷,王瑞民,陈英茂,等.多巴胺转运蛋白PET成像诊断帕金森病.中国医学影像学杂志,2008,16(2):94-97.

[14]

Nurmi E,Ruottinen HM,Kaasinen V,et al.Progression in Parkinson's disease:a positron emission tomography study with a dopamine transporter ligand[¹⁸F] CFT.Ann Neurol,2000,47(6):804-808.